J. Hunt

发表

Antagonizing somatostatin receptor subtype 2 and 5 reduces blood glucose in a gut- and GLP-1R–dependent manner

Rainer E. Martin, J. Holst, J. Pedersen, 2021, JCI insight.

Glucose- and Bile Acid-Stimulated Secretion of Gut Hormones in the Isolated Perfused Intestine Is Not Impaired in Diet-Induced Obese Mice

J. Holst, S. L. Jepsen, J. Hunt, 2022, Frontiers in Endocrinology.

Neprilysin Inhibition Increases Glucagon Levels in Humans and Mice With Potential Effects on Amino Acid Metabolism

J. Holst, M. Rosenkilde, C. Deacon, 2021, Journal of the Endocrine Society.

Pharmacological activation of TGR5 promotes intestinal growth via a GLP-2 dependent pathway in mice.

J. Holst, J. Windeløv, B. Hartmann, 2020, American journal of physiology. Gastrointestinal and liver physiology.

Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis.

J. Holst, J. Pedersen, S. Poulsen, 2018, American journal of physiology. Endocrinology and metabolism.

Glucagon-Like Peptide 1 and Atrial Natriuretic Peptide in a Female Mouse Model of Obstructive Pulmonary Disease

J. Holst, J. Windeløv, J. Hunt, 2019, Journal of the Endocrine Society.

NATRIURETIC PEPTIDE IN A FEMALE MOUSE MODEL OF OBSTRUCTIVE PULMONARY DISEASE

J. Holst, J. Windeløv, J. Hunt, 2019 .

Intestinal Growth in Glucagon Receptor Knockout Mice Is Not Associated With the Formation of AOM/DSS-Induced Tumors

J. Holst, B. Hartmann, J. Olsen, 2021, Frontiers in Endocrinology.

Opposing effects of chronic glucagon receptor agonism and antagonism on amino acids, hepatic gene expression, and alpha cells

J. Holst, T. Kruse, N. J. Wewer Albrechtsen, 2022, iScience.

Glucose‐dependent insulinotropic polypeptide receptor antagonist treatment causes a reduction in weight gain in ovariectomised high fat diet‐fed mice

J. Holst, M. Rosenkilde, J. Windeløv, 2022, British journal of pharmacology.

Dietary Fiber Is Essential to Maintain Intestinal Size, L-Cell Secretion, and Intestinal Integrity in Mice

J. Holst, B. Hartmann, K. Schoonjans, 2021, Frontiers in Endocrinology.

Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis

J. Holst, M. Gillum, J. Pedersen, 2020, Molecular metabolism.

GLP-1 and Intestinal Diseases

J. Holst, J. Hunt, H. Kissow, 2021, Biomedicines.

Novel agonist and antagonist radioligands for the GLP‐2 receptor. Useful tools for studies of basic GLP‐2 receptor pharmacology

J. Holst, M. Rosenkilde, J. Windeløv, 2021, British journal of pharmacology.

Intestinal Adaptation upon Chemotherapy-Induced Intestinal Injury in Mice Depends on GLP-2 Receptor Activation

J. Holst, Anna Billeschou, J. Hunt, 2021, Biomedicines.

Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice

J. Holst, M. Rosenkilde, T. Kruse, 2022, Molecular metabolism.

Biased GLP‐2 agonist with strong G protein‐coupling but impaired arrestin recruitment and receptor desensitization enhances intestinal growth in mice

J. Holst, M. Rosenkilde, B. Hartmann, 2023, British journal of pharmacology.

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis.

Anna Billeschou, J. Hunt, H. Kissow, 2019, Journal of Visualized Experiments.

Novel agonist- and antagonist-based radioligands for the GLP-2 receptor - useful tools for studies of basic GLP-2R pharmacology

M. Rosenkilde, J. Windeløv, C. Ørskov, 2022 .

The Severity of DSS-Induced Colitis Is Independent of the SCFA-FFAR2/3-GLP-1 Pathway Despite SCFAs Inducing GLP-1 Secretion via FFAR2/3

J. Hunt, H. Kissow, C. Christiansen, 2024, Metabolites.